These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20635413)

  • 21. Unidentified drugs in traditional medications causing toxic epidermal necrolysis: a developing country experience.
    Kumar Das K; Khondokar S; Rahman A; Chakraborty A
    Int J Dermatol; 2014 Apr; 53(4):510-5. PubMed ID: 24673145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lupus-associated toxic epidermal necrolysis: a novel manifestation of lupus?
    Mandelcorn R; Shear NH
    J Am Acad Dermatol; 2003 Apr; 48(4):525-9. PubMed ID: 12664014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxic epidermal necrolysis-like lesions as a manifestation of lupus erythematosus: the clinical picture of two cases.
    Rubio-González B; Angulo-Martínez L; Vanaclocha-Sebastián F; Postigo-Llorente C; Llamas-Martín R
    Arthritis Rheumatol; 2014 Jun; 66(6):1607. PubMed ID: 24577870
    [No Abstract]   [Full Text] [Related]  

  • 24. Ciprofloxacin-induced toxic epidermal necrolysis.
    Moshfeghi M; Mandler HD
    Ann Pharmacother; 1993 Dec; 27(12):1467-9. PubMed ID: 8305780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
    Sane SP; Bhatt AD
    J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.
    Gerull R; Nelle M; Schaible T
    Crit Care Med; 2011 Jun; 39(6):1521-32. PubMed ID: 21358399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Etoricoxib Induced Toxic Epidermal Necrolysis in a case of Systemic Lupus Erythematosus: A Case Report.
    Pandey A; Parajuli S; Dhungel A; Devkota R; Dongol A
    JNMA J Nepal Med Assoc; 2022 Sep; 60(253):811-814. PubMed ID: 36705131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Toxic epidermal necrolysis and necrotizing fasciitis. 2 severe emergencies with dermatologic presentation].
    Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 1997 Sep; 52(9):593-7. PubMed ID: 9441343
    [No Abstract]   [Full Text] [Related]  

  • 29. [Toxic epidermal necrolysis (syndrome Lyell) versus Stevens-Johnson syndrome].
    Jezierska-Krupa B; Hyla-Klekot L
    Pediatr Pol; 1996 Jul; 71(7):615-20. PubMed ID: 8803466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stevens-Johnson syndrome/toxic epidermal necrolysis-like cutaneous lupus erythematosus. A case series with long-term follow-up.
    Marti-Marti I; Morgado-Carrasco D; Carrera C; Alamon-Reig F; Serra-García L; Mascaró JM
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):e135-e139. PubMed ID: 34551165
    [No Abstract]   [Full Text] [Related]  

  • 31. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxic epidermal necrolysis after therapeutic plasma exchange in pediatric lupus patients and associated risk factors analysis.
    Lu J; Dong L; Zhang L; Zhang H; Wang L; Zhang J; Wan C
    Lupus; 2021 Mar; 30(3):465-472. PubMed ID: 33413003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Advances in understanding of the pathophysiology of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis)].
    Lalevée S; Contassot E; Ortonne N; Gaudin O; Ben Said B; Vocanson M; De Prost N; Wolkenstein P; Hue S; Ingen-Housz-Oro S
    Ann Dermatol Venereol; 2020; 147(6-7):475-481. PubMed ID: 32253008
    [No Abstract]   [Full Text] [Related]  

  • 34. Toxic epidermal necrolysis-like lupus.
    Roberts EJ; Melchionda V; Saldanha G; Shaffu S; Royle J; Harman KE
    Clin Exp Dermatol; 2021 Oct; 46(7):1299-1303. PubMed ID: 33760256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
    Tan SK; Tay YK
    Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stevens-Johnson syndrome in a juvenile systemic lupus erythematosus patient.
    Cavalcante EG; Guissa VR; Jesus AA; Campos LM; Sallum AM; Aikawa NE; Silva CA
    Lupus; 2011 Nov; 20(13):1439-41. PubMed ID: 21768172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus and the spectrum of the acute syndrome of apoptotic pan-epidermolysis (ASAP): a case report, concept review and proposal for new classification of lupus erythematosus vesiculobullous skin lesions.
    Ting W; Stone MS; Racila D; Scofield RH; Sontheimer RD
    Lupus; 2004; 13(12):941-50. PubMed ID: 15645750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis associated with lupus erythematosus.
    Torchia D; Romanelli P; Kerdel FA
    J Am Acad Dermatol; 2012 Sep; 67(3):417-21. PubMed ID: 22101216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skin signs of severe systemic medication reactions.
    Treat JR
    Curr Probl Pediatr Adolesc Health Care; 2012 Sep; 42(8):193-7. PubMed ID: 22884025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxic epidermal necrolysis and Stevens-Johnson syndrome: things we should know!
    Kamolz LP; Spendel S; Prandl EC
    Crit Care Med; 2011 Jun; 39(6):1600-1. PubMed ID: 21610649
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.